Celcuity
CELC • NASDAQ
Celcuity is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Brian F. Sullivan, with a market cap of $4.8B.
CEOBrian F. Sullivan
Market Cap$4.8B
Biotechnology
Healthcare
Employees55.0
Websitecelcuity.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Celcuity
Date
Monday, March 30, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$1.03
Earnings History
Past 12 earnings reports for Celcuity
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 12, 2025 | Q3 2025 | -$0.78Est: -$0.99 | +21.2% | - | — |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.93Est: -$0.87 | -6.9% | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.81Est: -$0.86 | +5.8% | - | — | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$0.75Est: -$0.67 | -11.9% | - | — | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.65Est: -$0.70 | +7.1% | - | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.58Est: -$0.68 | +14.7% | - | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$0.59Est: -$0.71 | +16.9% | - | — | 10-Q |
| Mar 27, 2024 | Q4 2023 | -$0.61Est: -$0.73 | +16.4% | - | — | 10-K |
| Nov 13, 2023 | Q3 2023 | -$0.78Est: -$0.68 | -14.7% | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$0.58Est: -$0.60 | +3.3% | - | — | 10-Q |
| May 15, 2023 | Q1 2023 | -$0.47Est: -$0.52 | +9.6% | - | — | 10-Q |
| Mar 23, 2023 | Q4 2022 | -$0.60Est: -$0.44 | -36.4% | - | — | — |